108 related articles for article (PubMed ID: 7857709)
1. Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).
Ohtsu A; Shimada Y; Yoshida S; Saito H; Seki S; Morise K; Kurihara M
Eur J Cancer; 1994; 30A(14):2091-3. PubMed ID: 7857709
[TBL] [Abstract][Full Text] [Related]
2. Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer.
Kondo K; Murase M; Kodera Y; Akiyama S; Ito K; Yokoyama Y; Takagi H; Shirasaka T
Oncology; 1996; 53(1):64-7. PubMed ID: 8570135
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Miyakita M; Ogata Y
Jpn J Clin Oncol; 1998 May; 28(5):314-7. PubMed ID: 9703858
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
[TBL] [Abstract][Full Text] [Related]
7. An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer.
Ohtsu A; Yoshida S; Saito D; Shimada Y; Miyamoto K; Fujii T; Yoshino M; Yoshimori M
Jpn J Clin Oncol; 1991 Apr; 21(2):120-4. PubMed ID: 2067126
[TBL] [Abstract][Full Text] [Related]
8. Bolus and infusional 5-fluorouracil combined with cisplatin in advanced gastric cancer.
Barone C; Cassano A; Landriscina M; Longo R; Astone A; Pozzo C
Oncol Rep; 2000; 7(6):1305-9. PubMed ID: 11032934
[TBL] [Abstract][Full Text] [Related]
9. An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer.
Kim R; Nishimoto N; Inoue H; Yoshida K; Toge T
J Infect Chemother; 2000 Dec; 6(4):222-8. PubMed ID: 11810570
[TBL] [Abstract][Full Text] [Related]
10. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial.
Lacave AJ; Barón FJ; Antón LM; Estrada E; De Sande LM; Palacio I; Esteban E; Gracia JM; Buesa JM; Fernández OA
Ann Oncol; 1991; 2(10):751-4. PubMed ID: 1801881
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Kelleher M; Tebbutt NC; Cunningham D; Andreyev J; Allen M; Hill M; Norman A
Clin Oncol (R Coll Radiol); 2003 May; 15(3):92-7. PubMed ID: 12801044
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis.
Rougier P; Ducreux M; Mahjoubi M; Pignon JP; Bellefqih S; Oliveira J; Bognel C; Lasser P; Ychou M; Elias D
Eur J Cancer; 1994; 30A(9):1263-9. PubMed ID: 7999410
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
Zhang CX; Huang S; Xu N; Fang JW; Shen P; Bao YH; Mou BH; Shi MG; Zhong XL; Xiong PJ
Anticancer Drugs; 2007 Jun; 18(5):581-6. PubMed ID: 17414627
[TBL] [Abstract][Full Text] [Related]
15. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
16. [Weekly regimen of paclitaxel liposome combined with cisplatin and 5-fluorouracil continuous infusion in the treatment of advanced gastric carcinoma].
Li JH; Li B; Jiang HR; Zhong MZ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):229-31. PubMed ID: 21575526
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of two infusion schedules of irinotecan combined with cisplatin in patients with advanced gastric cancer.
Fujitani K; Tsujinaka T; Hirao M
Oncology; 2003; 64(2):111-5. PubMed ID: 12566907
[TBL] [Abstract][Full Text] [Related]
18. [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].
Hu B; Yu JR; Wen ZZ; Shu YQ; Wang BC; Yin HR; Chen L; Bai YX; Liang J; Chen L; Cheng Y; Shen L; Zhou Y; Zhang HG; Li J; Wan DS; Chen S; Jia TZ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):940-3. PubMed ID: 19173999
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacón I; Garrido P; Colmenarejo A; Ordóñez A; Zamora P
Cancer Chemother Pharmacol; 1995; 36(3):255-8. PubMed ID: 7781148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
